Overview

Convalescent Plasma in Pediatric COVID-19

Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
COVID-19 is increasingly affecting children but convalescent plasma (CP) has not been adequately studied in children to date. The study will determine safety of convalescent plasma for pediatric patients with severe, or at high risk for severe, COVID-19 disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
Emory University